RNA Research Solutions
-   B7972 Pseudo-UTPSummary: Pseudo-modified uridine triphosphate, can replace UTP for in vitro mRNA transcription synthesis. B7972 Pseudo-UTPSummary: Pseudo-modified uridine triphosphate, can replace UTP for in vitro mRNA transcription synthesis.
-   R1017 EZ Cap™ mCherry mRNA (5mCTP, ψUTP)4 CitationSummary: mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. R1017 EZ Cap™ mCherry mRNA (5mCTP, ψUTP)4 CitationSummary: mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-   K1065 HyperScribe™ All in One mRNA Synthesis Kit Plus 2 (ARCA, 5-moUTP, T7, poly(A))Summary: Used for the in vitro synthesis of mRNA (ARCA capped, 5-moUTP modified, poly(A) tailed) K1065 HyperScribe™ All in One mRNA Synthesis Kit Plus 2 (ARCA, 5-moUTP, T7, poly(A))Summary: Used for the in vitro synthesis of mRNA (ARCA capped, 5-moUTP modified, poly(A) tailed)
-   M2006 DMG-PEG2000-NH₂Summary: NH₂-PEG derivatives, used for liposomal delivery M2006 DMG-PEG2000-NH₂Summary: NH₂-PEG derivatives, used for liposomal delivery
-   R1039 EZ Cap™ Human P16 mRNA (ψUTP)Summary: Human p16 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. R1039 EZ Cap™ Human P16 mRNA (ψUTP)Summary: Human p16 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-   B7967 5-Methyl-CTPSummary: 5-Methyl modified cytidine triphosphate for in vitro transcription synthesis of mRNA B7967 5-Methyl-CTPSummary: 5-Methyl modified cytidine triphosphate for in vitro transcription synthesis of mRNA
-   R1016 EZ Cap™ EGFP mRNA (5-moUTP)16 CitationSummary: EGFP mRNA with Cap 1 structure, modified by 5-moUTP,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. R1016 EZ Cap™ EGFP mRNA (5-moUTP)16 CitationSummary: EGFP mRNA with Cap 1 structure, modified by 5-moUTP,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-   K1064 HyperScribe™ All in One mRNA Synthesis Kit Plus 1 (ARCA, 5mCTP, ψUTP, T7, poly(A))Summary: Used for the in vitro synthesis of mRNA (ARCA capped, 5mCTP and ψUTP modified, poly(A) tailed) K1064 HyperScribe™ All in One mRNA Synthesis Kit Plus 1 (ARCA, 5mCTP, ψUTP, T7, poly(A))Summary: Used for the in vitro synthesis of mRNA (ARCA capped, 5mCTP and ψUTP modified, poly(A) tailed)
-   R1075 EZ Cap™ Mouse RLI mRNA (m1Ψ)Summary: Mouse RLI mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. R1075 EZ Cap™ Mouse RLI mRNA (m1Ψ)Summary: Mouse RLI mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-   R1038 EZ Cap™ Human P16 mRNASummary: Human p16 mRNA with Cap 1 structure, providing high transcriptional efficiency R1038 EZ Cap™ Human P16 mRNASummary: Human p16 mRNA with Cap 1 structure, providing high transcriptional efficiency
